INKT MiNK Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Visualizza su SEC EDGAR ↗ chiudi Ott 2, 2026 10-K/10-Q Ago 13, 2026
$12,44
· % dell'intervallo 52 sett.
· sopra il minimo
· al massimo
$8,48minimo 52 sett.
$16,93massimo 52 sett.
Capitalizzazione di Mercato (MRQ)
$63M
P/E
-3.8
EPS
$-2.93
i tuoi badge
Intervallo 52 sett.
$8–$17
Rating Analisti
BUY
Prezzo Obiettivo
$39
P/E
-3.8
ROE
63.4%
Margine di Profitto Netto
-6931.8%
La tua barra dei badge è vuota — aggiungi una metrica a piacere in questa pagina.
INKT Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$12.44
Capitalizzazione di Mercato (MRQ)
$63M
P/E
-3.8
EPS
$-2.93
ROE
63.4%
Intervallo 52 sett.
$8–$17
INKT Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
intervallo
barre
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Split azionari
| Data ex-dividendo | Split | Tipo |
|---|---|---|
| 28 Gennaio 2025 | 1-for-10 | Inverso |
Performance decennale Andamento di ricavi, utile netto, margini e EPS
EPS$-2.932021-12-31 → 2025-12-31
Flusso di cassa libero·2021-12-31 → 2023-12-31
Margine netto-6931.8%2022-12-31 → 2025-12-31
Valutazione e Rapporti
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | INKT | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E | -3.8media 5 anni ≈-15.6 | ≈-15.6 | · | · | |
| P/B (MRQ) | -4.5media 5 anni ≈-741.3 | ≈-741.3 | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | INKT | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Operating Margin (Margine Operativo) | -7013.8%media 5 anni ≈-7680.1% | ≈-7680.1% | -2571.0% | Sotto la media | |
| EBITDA Margin (Margine EBITDA) | -7013.8%media 5 anni ≈-7680.1% | ≈-7680.1% | -2571.0% | Sotto la media | |
| Net Profit Margin (Margine di Profitto Netto) | -6931.8%media 5 anni ≈-7269.7% | ≈-7269.7% | -2615.5% | Sotto la media | |
| ROA | -125.2%media 5 anni ≈-146.7% | ≈-146.7% | -69.9% | Debole | |
| ROE | 63.4%media 5 anni ≈-100.6% | ≈-100.6% | -65.7% | Di prim'ordine |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | INKT | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Rapporto corrente (MRQ) | 1.2media 5 anni ≈1.2 | ≈1.2 | 3.1 | Bassa liquidità | |
| Quick Ratio | 1.0media 5 anni ≈1.2 | ≈1.2 | 2.1 | Bassa liquidità | |
| Interest Coverage (Copertura degli interessi) | 114.9media 5 anni ≈74.9 | ≈74.9 | -22.8 | Liquidità elevata |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
| Metrica | Tendenza 5 anni | INKT | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Revenue YoY (Ricavi YoY) | 4.5%media 5 anni ≈8.2% | ≈8.2% | · | · | |
| Revenue CAGR 3Y (CAGR Ricavi 3Y) | -10.7% | · | · | · |
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
| Metrica | Tendenza 5 anni | INKT | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Asset Turnover (Rotazione delle attività) | 0.0media 5 anni ≈0.0 | ≈0.0 | 0.0 | Di prim'ordine |
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
-5.6%
Prossimo report
Nov 12, 2026
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 30 Giugno 2026 | Ago 13, 2026 | $-0.62 | $-0.61 | -1.3% |
| 31 Marzo 2026 | Mag 15, 2026 | $-0.57 | $-0.79 | 27.4% |
| 31 Dicembre 2025 | $-0.56 | $-0.84 | 33.6% | |
| 30 Settembre 2025 | $-0.65 | $-0.87 | 25.5% | |
| 30 Giugno 2025 | $-1.06 | $-0.56 | -90.1% | |
| 31 Marzo 2025 | $-0.70 | $-0.62 | -12.5% | |
| 31 Dicembre 2024 | $-0.62 | $-0.51 | -21.6% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $6M | $6M | $15M | $23M | $14M | $10M | |
| SG&A Expense | $7M | $4M | $7M | $8M | $5M | $1M | |
| Operating Income | $-13M | $-11M | $-23M | $-31M | $-28M | $-15M | |
| Interest Expense | $-110.0K | $-93.0K | $-28.0K | · | $2M | $2M | |
| Other Non-op | $-32.4K | $330.9K | $-10 | $3M | $221.9K | $839.2K | |
| Net Income | $-12M | $-11M | $-22M | $-28M | $-30M | $-16M | |
| EPS (Basic) | $-2.93 | $-2.86 | $-6.54 | $-0.83 | $-1.16 | · | |
| EPS (Diluted) | $-2.93 | $-2.86 | $-6.54 | $-0.83 | $-1.16 | · | |
| Shares (Basic) | 4,270,470 | 3,773,326 | 3,435,994 | 33,672,927 | 26,025,489 | · | |
| Shares (Diluted) | 4,270,470 | 3,773,326 | 3,435,994 | 33,672,927 | 26,025,489 | · | |
| EBITDA | $-13M | $-11M | $-23M | $-31M | $-28M | · |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $13M | $5M | $3M | $20M | $39M | $3M | |
| Prepaid Expense | $276.4K | $246.6K | $53.1K | $298.7K | $1.8K | $492.1K | |
| Other Current Assets | $211.2K | $164.2K | $178.0K | $470.3K | $744.3K | $913.6K | |
| Current Assets | $14M | $5M | $4M | $20M | $40M | $4M | |
| PP&E (Net) | $390.9K | $732.9K | $954.0K | $1M | $606.6K | $458.4K | |
| PP&E (Gross) | $1M | $1M | $1M | $1M | $776.0K | $556.0K | |
| Accum. Depreciation | $612.2K | $524.6K | $495.6K | $283.7K | $168.6K | $98.2K | |
| Total Assets | $14M | $6M | $5M | $21M | $40M | $5M | |
| Accounts Payable | $3M | $3M | $4M | $6M | $3M | $3M | |
| Accrued Liabilities | $2M | $2M | $5M | $4M | $2M | $2M | |
| Current Liabilities | $13M | $7M | $11M | $13M | $16M | $14M | |
| Other Non-current Liabilities | · | $0 | $48.1K | $108.5K | · | $383.1K | |
| Common Stock | $48 | $40 | $35 | $339 | $335 | $242 | |
| Retained Earnings | $-157M | $-144M | $-133M | $-111M | $-83M | $-53M | |
| AOCI | $-718.9K | $-631.6K | $-430.9K | $-292.5K | $-625.3K | $-2M | |
| Stockholders' Equity | $-14M | $-20M | $-18M | $-401.3K | $24M | $-54M | |
| Liabilities + Equity | $14M | $6M | $5M | $21M | $40M | $5M | |
| Shares Outstanding | 4,706,246 | 3,963,045 | 3,459,910 | 33,856,428 | 33,476,523 | · |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $3M | $2M | $4M | $3M | $2M | $87.8K | |
| Operating Cash Flow | $-6M | $-10M | $-16M | $-19M | $-13M | $-8M | |
| CapEx | · | · | $73.6K | $250.0K | $249.0K | $95.2K | |
| Investing Cash Flow | · | · | $-73.6K | $-250.0K | $-249.0K | $-95.2K | |
| Debt Issued | · | · | · | · | · | $355.5K | |
| Financing Cash Flow | $15M | $11M | $-407.2K | $-155.6K | $49M | $11M | |
| Net Change in Cash | $9M | $1M | $-16M | $-19M | $36M | $2M | |
| Free Cash Flow | · | · | $-16M | $-19M | $-13M | · |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -7013.8% | -6541.4% | -4947.8% | -12217.3% | · | · | |
| Net Margin | -6931.8% | -6249.6% | -4847.8% | -11049.6% | · | · | |
| EBITDA Margin | -7013.8% | -6541.4% | -4947.8% | -12217.3% | · | · | |
| ROA | -125.2% | -210.0% | -172.6% | -90.7% | -134.9% | · | |
| ROE | 63.4% | 58.1% | 142.0% | -880.9% | 114.6% | · |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 0.7 | 0.3 | 1.6 | 2.4 | · | |
| Quick Ratio | 1.0 | 0.7 | 0.3 | 1.5 | 2.4 | · | |
| Interest Coverage | 114.9 | 121.4 | · | · | -11.7 | · |
Efficienza
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | · | · |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $-4.94 | $-0.52 | $-0.01 | · | · | |
| Revenue / Share | $0.04 | $0.05 | $0.01 | $0.01 | · | · | |
| Cash Flow / Share | $-1.39 | $-2.53 | $-0.46 | $-0.56 | · | · | |
| Cash / Share | · | $1.15 | $0.10 | $0.58 | · | · | |
| EPS (TTM) | $-2.93 | $-2.86 | $-6.54 | $-0.83 | $-1.16 | · |
Tassi di Crescita
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 4.5% | -62.7% | 82.9% | · | · | · | |
| Revenue CAGR 3Y | -10.7% | · | · | · | · | · |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $180.2K | $172.6K | $463.3K | $253.3K | $-2M | · | |
| Net Income TTM | $-12M | $-11M | $-22M | $-28M | $-30M | · | |
| Market Cap | · | $28M | $370M | $884M | · | · | |
| P/E | -3.8 | -2.4 | -1.6 | -31.4 | -38.4 | · | |
| P/S | · | 160.1 | 799.1 | 3488.2 | · | · | |
| P/B | · | -1.4 | -20.5 | -2202.0 | · | · | |
| P / Cash Flow | · | -2.9 | -23.5 | -46.8 | · | · | |
| P / FCF | · | · | -23.4 | -46.2 | · | · | |
| Earnings Yield | -26.3% | -41.0% | -61.1% | -3.2% | -2.6% | · |
Conto Economico
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $2M | $1M | $2M | $1M | $2M | $1M | $1M | $540.6K | $2M | $3M | $3M | $3M | $5M | $4M | $6M | $6M | |
| SG&A Expense | $1M | $2M | $2M | $2M | $2M | $1M | $808.9K | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Operating Income | $-3M | $-3M | $-3M | $-3M | $-4M | $-3M | $-3M | $-2M | $-3M | $-4M | $-6M | $-5M | $-6M | $-6M | $-8M | $-8M | |
| Interest Expense | $-2.0K | $-4.0K | $-29.0K | $-25.0K | $-27.0K | $-29.0K | $-29.0K | $-28.0K | $-26.0K | $-10.0K | · | · | · | · | · | · | |
| Other Non-op | $15.8K | $58.6K | $-7.9K | $240.7K | $-185.7K | $-79.5K | $0 | $0 | $330.9K | · | $-18 | $8 | · | · | $-15.4K | $2M | |
| Net Income | $-3M | $-3M | $-3M | $-3M | $-4M | $-3M | $-2M | $-2M | $-3M | $-4M | $-5M | $-5M | $-6M | $-6M | $-8M | $-6M | |
| EPS (Basic) | $-0.62 | $-0.57 | $-0.52 | $-0.65 | $-1.06 | $-0.70 | $-0.57 | $-0.46 | $-0.73 | $-1.10 | $-6.04 | $-0.15 | $-0.18 | $-0.17 | $-0.23 | $-0.19 | |
| EPS (Diluted) | $-0.62 | $-0.57 | $-0.52 | $-0.65 | $-1.06 | $-0.70 | $-0.57 | $-0.46 | $-0.73 | $-1.10 | $-6.04 | $-0.15 | $-0.18 | $-0.17 | $-0.23 | $-0.19 | |
| Shares (Basic) | 5,023,450 | 4,797,833 | · | 4,443,262 | 3,981,992 | 3,964,982 | · | 3,953,370 | 3,714,202 | 3,464,292 | · | 34,497,595 | 34,409,064 | 33,966,921 | · | 33,757,164 | |
| Shares (Diluted) | 5,023,450 | 4,797,833 | · | 4,443,262 | 3,981,992 | 3,964,982 | · | 3,953,370 | 3,714,202 | 3,464,292 | · | 34,497,595 | 34,409,064 | 33,966,921 | · | 33,757,164 | |
| EBITDA | $-3M | $-3M | · | $-3M | $-4M | $-3M | · | $-2M | $-3M | $-4M | · | $-5M | $-6M | $-6M | · | $-8M |
Stato Patrimoniale
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $9M | $10M | $13M | $14M | $2M | $3M | $5M | $6M | $9M | $6M | $3M | $6M | $11M | $15M | $20M | $24M | |
| Prepaid Expense | $277.6K | $264.5K | $276.4K | $253.1K | $274.1K | $236.2K | $246.6K | $235.8K | $98.8K | $59.4K | $53.1K | $42.0K | $265.8K | $309.1K | $298.7K | $262.9K | |
| Other Current Assets | $212.2K | $232.3K | $211.2K | $32 | $55.2K | $108.7K | $164.2K | $11.2K | $61.1K | $122.5K | $178.0K | $29.3K | $166.0K | $320.9K | $470.3K | $37.5K | |
| Current Assets | $9M | $10M | $14M | $15M | $2M | $4M | $5M | $7M | $9M | $6M | $4M | $6M | $11M | $16M | $20M | $24M | |
| PP&E (Net) | $318.5K | $354.5K | $390.9K | $429.3K | $473.2K | $687.5K | $732.9K | $799.5K | $850.0K | $895.0K | $954.0K | $991.5K | $1M | $1M | $1M | $803.1K | |
| PP&E (Gross) | · | · | $1M | · | · | · | $1M | · | · | · | $1M | · | · | · | $1M | · | |
| Accum. Depreciation | $683.8K | $647.8K | $612.2K | $573.6K | $530.6K | $578.5K | $524.6K | $476.7K | $409.0K | $545.1K | $495.6K | $432.5K | $385.6K | $332.6K | $283.7K | $232.8K | |
| Total Assets | $10M | $10M | $14M | $15M | $2M | $4M | $6M | $7M | $10M | $7M | $5M | $7M | $12M | $17M | $21M | $25M | |
| Accounts Payable | $4M | $3M | $3M | $4M | $3M | $3M | $3M | $2M | $3M | $3M | $4M | $4M | $5M | $6M | $6M | $5M | |
| Accrued Liabilities | $1M | $1M | $2M | $1M | $2M | $2M | $2M | $3M | $5M | $5M | $5M | $4M | $4M | $3M | $4M | $3M | |
| Current Liabilities | $8M | $7M | $13M | $13M | $13M | $12M | $7M | $7M | $10M | $11M | $11M | $10M | $11M | $11M | $13M | $18M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | $2.9K | $23.3K | $31.6K | $48.1K | $64.0K | $79.3K | $94.2K | $108.5K | $58.3K | |
| Common Stock | $52 | $51 | $48 | $46 | $40 | $40 | $40 | $395 | $394 | $347 | $35 | $345 | $345 | $343 | $339 | $338 | |
| Retained Earnings | $-163M | $-159M | $-157M | $-154M | $-151M | $-147M | $-144M | $-142M | $-140M | $-137M | $-133M | $-128M | $-123M | $-117M | $-111M | $-103M | |
| AOCI | $-699.9K | $-697.4K | $-718.9K | $-692.1K | $-719.3K | $-662.4K | $-631.6K | $-672.8K | $-611.4K | $-385.8K | $-430.9K | $-313.2K | $-401.8K | $-373.8K | $-292.5K | $-78.3K | |
| Stockholders' Equity | $-14M | $-13M | $-14M | $-14M | $-25M | $-22M | $-20M | $-18M | $-17M | $-20M | $-18M | $-14M | $-9M | $-4M | $-401.3K | $7M | |
| Liabilities + Equity | $10M | $10M | $14M | $15M | $2M | $4M | $6M | $7M | $10M | $7M | $5M | $7M | $12M | $17M | $21M | $25M | |
| Shares Outstanding | 5,096,658 | · | · | · | · | · | · | · | · | · | 3,459,910 | · | · | · | 33,856,428 | · |
Flusso di cassa
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $422.2K | $630.4K | $565.8K | $620.6K | $896.6K | $591.1K | $390.0K | $391.3K | $436.9K | $592.0K | $1M | $939.3K | $898.3K | $921.1K | $667.6K | $772.9K | |
| Operating Cash Flow | $-2M | $-2M | $-2M | $-941.3K | $-2M | $-1M | $-2M | $-3M | $-2M | $-3M | $-3M | $-4M | $-4M | $-4M | $-4M | $-6M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | $0 | $23.0K | $37.0K | $13.5K | $127.8K | $59.8K | |
| Investing Cash Flow | · | · | · | · | · | · | · | · | · | · | $0 | $-23.0K | $-37.0K | $-13.5K | $-127.8K | $-59.8K | |
| Financing Cash Flow | $1M | $-2M | $1M | $14M | $540 | $576 | $-3 | $6.8K | $6M | $5M | $-2 | $3.0K | $-75.7K | $-334.4K | $111 | $494 | |
| Net Change in Cash | $-718.7K | $-4M | $-920.9K | $13M | $-2M | $-1M | $-2M | $-3M | $3M | $2M | $-3M | $-4M | $-4M | $-5M | $-5M | $-6M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | $-4M | · | · |
Redditività
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -4413.7% | -3565.1% | · | -5772.5% | -1164481.6% | -19979.9% | · | -2415.7% | -8005.9% | -23045.4% | · | -4868.8% | -4333.2% | -3483.4% | · | -8592.2% | |
| Net Margin | -4292.0% | -3392.6% | · | -5236.0% | -1217744.5% | -20468.3% | · | -2315.7% | -7043.3% | -22945.4% | · | -4768.8% | -4233.2% | -3383.4% | · | -6811.1% | |
| EBITDA Margin | -4413.7% | -3565.1% | · | -5772.5% | -1164481.6% | -19979.9% | · | -2415.7% | -8005.9% | -23045.4% | · | -4868.8% | -4333.2% | -3483.4% | · | -8592.2% | |
| ROA | -51.7% | -37.5% | · | -25.9% | -66.2% | -49.6% | · | -24.3% | -24.1% | -32.5% | · | -31.3% | -28.7% | -21.6% | · | -43.2% | |
| ROE | 16.0% | 15.9% | · | 18.6% | 20.3% | 13.2% | · | 11.6% | 20.7% | 30.8% | · | 149.9% | -295.5% | -88.6% | · | 18.1% |
Liquidità e Solvibilità
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | 1.4 | · | 1.1 | 0.2 | 0.3 | · | 0.9 | 0.9 | 0.5 | · | 0.6 | 1.0 | 1.4 | · | 1.3 | |
| Quick Ratio | 1.2 | 1.3 | · | 1.1 | 0.1 | 0.3 | · | 0.9 | 0.9 | 0.5 | · | 0.6 | 0.9 | 1.3 | · | 1.3 | |
| Interest Coverage | 1608.4 | 720.4 | · | 127.3 | 150.1 | 93.1 | · | · | · | · | · | · | · | · | · | · |
Efficienza
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 |
Per Azione
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-2.75 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Revenue / Share | $0.01 | $0.02 | · | $0.01 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | |
| Cash Flow / Share | · | $-0.36 | · | · | · | $-0.34 | · | · | · | $-0.07 | · | · | · | $-0.13 | · | · | |
| Cash / Share | $1.73 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EPS (TTM) | $-2.36 | $-2.80 | · | $-2.98 | $-2.79 | $-2.46 | · | $-8.33 | $-8.02 | $-7.47 | · | $-0.73 | $-0.77 | $-0.77 | · | $-0.75 |
Valutazione (TTM)
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $320.1K | $247.6K | · | $108.6K | $131.5K | $169.5K | · | $174.5K | $203.8K | $311.8K | · | $556.6K | $542.2K | $422.2K | · | $116.9K | |
| Net Income TTM | $-11M | $-12M | · | $-12M | $-11M | $-10M | · | $-14M | $-17M | $-21M | · | $-25M | $-26M | $-26M | · | $-26M | |
| Market Cap | $60M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -5.0 | -3.8 | · | -4.7 | -2.6 | -3.5 | · | -0.9 | -1.2 | -1.2 | · | -15.1 | -27.3 | -24.6 | · | -28.1 | |
| P/S | 186.1 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/B | -4.2 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -20.2% | -26.6% | · | -21.3% | -37.8% | -28.5% | · | -111.1% | -84.5% | -82.3% | · | -6.6% | -3.7% | -4.1% | · | -3.5% |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Margine Operativo % | -7013.8% | -6541.4% | -4947.8% | -12217.3% | · |
| Utile netto | $-12M | $-11M | $-22M | $-28M | $-30M |
| EPS Diluito | $-2.93 | $-2.86 | $-6.54 | $-0.83 | $-1.16 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rapporto corrente | 1.1 | 0.7 | 0.3 | 1.6 | 2.4 |
| Quick Ratio | 1.0 | 0.7 | 0.3 | 1.5 | 2.4 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flusso di cassa libero | · | · | $-16M | $-19M | $-13M |
Proprietari istituzionali (13F) 27 filer · $3.1M totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Detentori
27
Valore detenuto
$3.1M
Nuove posizioni
7
Posizioni chiuse
3
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 7 (+2 vs trimestre precedente) | 3 (-1 vs trimestre precedente) | 6 (+4 vs trimestre precedente) | 3 (-1 vs trimestre precedente) | +78K |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $802.635 | 68.660 | 25,64% | Azioni |
| VANGUARD GROUP INC | $754.309 | 67.651 | 24,09% | Azioni |
| DNB Asset Management AS | $644.610 | 55.142 | 20,59% | Azioni |
| Longbow Finance SA | $194.837 | 16.667 | 6,22% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $182.077 | 15.573 | 5,82% | Azioni |
| CITADEL ADVISORS LLC | $180.494 | 15.440 | 5,76% | Azioni |
| BlackRock, Inc. | $156.435 | 13.382 | 5,00% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $96.875 | 8.287 | 3,09% | Azioni |
| UBS Group AG | $57.106 | 4.885 | 1,82% | Azioni |
| Steward Partners Investment Advisory, LLC | $23.380 | 2.000 | 0,75% | Azioni |
| US BANCORP \DE\ | $23.322 | 1.995 | 0,74% | Azioni |
| Federation des caisses Desjardins du Quebec | $5.845 | 500 | 0,19% | Azioni |
| Tower Research Capital LLC (TRC) | $4.933 | 422 | 0,16% | Azioni |
| OSAIC HOLDINGS, INC. | $1.366 | 117 | 0,04% | Azioni |
| MORGAN STANLEY | $1.321 | 113 | 0,04% | Azioni |
| BARCLAYS PLC | $281 | 24 | 0,01% | Azioni |
| Caitong International Asset Management Co., Ltd | $210 | 18 | 0,01% | Azioni |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $210 | 18 | 0,01% | Azioni |
| Game Plan Financial Advisors, LLC | $187 | 16 | 0,01% | Azioni |
| Clearstead Advisors, LLC | $164 | 14 | 0,01% | Azioni |
| BNP PARIBAS FINANCIAL MARKETS | $152 | 13 | 0,00% | Azioni |
| JPMORGAN CHASE & CO | $107 | 9 | 0,00% | Azioni |
| Key Financial Inc | $47 | 4 | 0,00% | Azioni |
| WELLS FARGO & COMPANY/MN | $23 | 2 | 0,00% | Azioni |
| LifeSteps Financial, Inc. | $23 | 2 | 0,00% | Azioni |
| JONES FINANCIAL COMPANIES LLLP | $12 | 1 | 0,00% | Azioni |
| Covestor Ltd | $1 | 119 | 0,00% | Azioni |
Attivisti e proprietari del 5%+ 1 partecipazione
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Garo H. Armen, The Garo H. Armen Grantor Retained Annuity Trust Agreement 2023 #1, The Garo H. Armen Grantor Retained Annuity Trust Agreement 2022 #1 | 14 Febbraio 2024 | · | Deposito iniziale | Investimento passivo | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 11 insider · 2 dirigenti · 8 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Jennifer Buell | Chief Executive Officer | 02 Gennaio 2026 F | 57.942 | 0 | 0 | $0 |
| Marcus Antonius Van Dijk | Chief Scientific Officer | 16 Gennaio 2024 A | 27.363 | 0 | 0 | $0 |
| John Bradley Holcomb | Direttore | 01 Settembre 2026 A | 4.691 | 0 | 0 | $0 |
| Peter Behner | Direttore | 01 Settembre 2026 A | 24.404 | 0 | 0 | $0 |
| Barbara Ryan | Direttore | 01 Settembre 2026 A | 23.591 | 0 | 8 | $-46.620 |
| Brian Corvese | Direttore | 01 Settembre 2026 A | 54.770 | 0 | 0 | $0 |
| Ulf Wiinberg | Direttore | 01 Settembre 2026 A | 23.929 | 0 | 0 | $0 |
| Robert Peter Kadlec | Direttore | 01 Dicembre 2025 A | 19.126 | 0 | 0 | $0 |
| John Baldoni | Direttore | 01 Settembre 2023 A | 41.193 | 0 | 0 | $0 |
| Garo H Armen | Direttore | 05 Maggio 2023 S | 1.866.400 | 0 | 0 | $0 |
| AGENUS INC | Proprietario del 10% | 16 Ottobre 2023 P | 21.772.863 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduti da 3 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
INKT Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
rating · 8 analisti
COMPRA
Target mediano
$39.00
+213,5%
2 25,0%
Acquisto forte
5 62,5%
Compra
1 12,5%
Mantieni
0 0,0%
Vendi
0 0,0%
Vendita forte
Target Price a 12 Mesi
2 analisti · 2026-10-03Target medio $39.00 +213,5%
← Sotto tutti i target
Prezzo attuale $12.44
Basso$35.00
Media$39.00
Alto$43.00
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| INKT | · | -3.8 | 4.5% | -6931.8% | 63.4% | · |
| IBIO | $97M | -5.5 | -75.0% | -33044.0% | -65.7% | · |
| APLM | · | -2.5 | · | -128.7% | -1305.4% | · |
| FBIO | · | · | · | · | · | · |
| NMAD | · | · | · | · | · | · |
| GOSS | $724M | -4.1 | -57.7% | -351.5% | 201.8% | · |
| FRMM | · | · | · | -6881.3% | -368.1% | · |
| ACET | · | -0.5 | · | · | · | · |
| BOLD | $27M | -0.5 | · | · | -46.7% | · |
| CNTB | $159M | -2.8 | -99.8% | -86687.5% | -97.9% | · |
| KLRS | $193M | -3.0 | · | · | -65.8% | · |
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Fonte: SEC 10-Q depositato Ago 13, 2026